Clinical Trial Update: AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions [NA]

View source ↗

Summary

A clinical trial is evaluating the safety and effectiveness of AGENT Drug-Coated Balloon versus standard PCI for de novo native coronary lesions. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• AGENT Drug-Coated Balloon

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Coronary Arterial Disease (CAD), de Novo Lesions in Native Coronary Arteries | NA | Status: RECRUITING